FDA recall record

RLC Labs Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg recall — FDA D-1615-2020

Subpotent Drug: FDA analysis found product to be subpotent

Class Iclassification
D-1615-2020official record ID
Sep 23, 2020report date

Recall record at a glance

Official recordD-1615-2020
CategoryDrug Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmRLC Labs Inc.
Report dateSep 23, 2020
Recall initiation dateAug 25, 2020
QuantityN/A
LocationPhoenix, AZ, United States

Official product description

Nature Throid, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 90-count bottles (NDC 64727-3299-6), b) 100-count bottles (NDC 64727-3299-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Why the product was recalled

Subpotent Drug: FDA analysis found product to be subpotent

Distribution information

Nationwide in the United States

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.